What other stocks do shareholders of Enveric Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Enveric Biosciences investors own include BOX (BOX) and Coty (COTY) .

How do I buy shares of Enveric Biosciences?

Shares of SPZR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:SPZR

Enveric Biosciences (SPZR) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free SPZR Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 12,294 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Enveric Biosciences alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Enveric Biosciences Stock (OTCMKTS:SPZR)

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

Find out more here >>>

SPZR Stock News Headlines

April 18, 2024 | msn.com

Enveric Biosciences (ENVB) Price Target Decreased by 11.11% to 8.16

March 19, 2024 | marketwatch.com

Enveric Biosciences Shares Pop 20% After Out-Licensing Deals Valued Up to $82M

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

February 29, 2024 | msn.com

Why Enveric Biosciences Stock Is Soaring

February 29, 2024 | msn.com

EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds

February 25, 2024 | msn.com

Enveric Biosciences (ENVB) Price Target Increased by 5.88% to 9.18

February 23, 2024 | msn.com

Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health Treatments

February 23, 2024 | marketwatch.com

Enveric Biosciences to Sell Cannabinoid-Related IP

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

February 13, 2024 | wsj.com

Pacira BioSciences Inc.

January 30, 2024 | realmoney.thestreet.com

Enveric Biosciences initiated with bullish view at H.C. Wainwright, here's why

January 11, 2024 | msn.com

Enveric Biosciences files to sell 2.24M shares for holders

November 14, 2023 | benzinga.com

Enveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials

November 8, 2023 | msn.com

Enveric Biosciences files to sell 1.2M shares for holders

August 28, 2023 | benzinga.com

Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment

July 17, 2023 | markets.businessinsider.com

Enveric Biosciences Reports Positive Results From Animal Studies With EB-373

May 18, 2023 | msn.com

Why Is Enveric Biosciences (ENVB) Stock Up 120% Today?

May 18, 2023 | marketwatch.com

Enveric Biosciences Shares Rise 40% After Notice of Allowance for Psilocin U.S. Patent

May 18, 2023 | msn.com

Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin

May 18, 2023 | msn.com

Enveric soars ~130% on upcoming US patent linked to psilocin prodrug EB-373 for anxiety

May 15, 2023 | markets.businessinsider.com

Enveric Biosciences Plans About 35 Percent Reduction In Full-time Personnel

May 15, 2023 | benzinga.com

Enveric Biosciences Reports First Quarter 2023 Financial Results and Operational Highlights

April 20, 2023 | msn.com

EXCLUSIVE: Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing Benefits

April 3, 2023 | seekingalpha.com

Enveric Biosciences GAAP EPS of -$13.00 misses by $0.54

March 1, 2023 | msn.com

Enveric Biosciences gets new finance chief

July 27, 2022 | apnews.com

Enveric Biosciences Appoints New Independent Directors

May 11, 2022 | seekingalpha.com

Enveric to spin out cannabinoid pipeline into a public company

See More Headlines

Receive SPZR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Computer and Technology
Industry: Data Processing Services
Sub-Industry: N/A
Current Symbol: OTCMKTS:SPZR
CUSIP: N/A
CIK: 890821
Web: www.ameri100.com
Phone: (239) 302-1707
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Joseph Tucker
Chief Executive Officer & Director
Avani V. Kanubaddi
President & Chief Operating Officer
Kevin M Coveney
Chief Financial Officer
Jillian Hagel
Chief Technology Officer
Bob Dagher
Chief Medical Officer

Key Competitors

View All Competitors

SPZR Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Enveric Biosciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Enveric Biosciences investors own include BOX (BOX) and Coty (COTY).
How do I buy shares of Enveric Biosciences?: Shares of SPZR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SPZR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Enveric Biosciences (SPZR) Stock Price, News & Analysis

About Enveric Biosciences Stock (OTCMKTS:SPZR)

SPZR Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

SPZR Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info